The cyclooxygenase-2 enzyme inhibition activity of 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives is quantitatively analyzed through Fujita-Ban and Hansch type of approaches. The analyses have helped to ascertain the role of different substituents in explaining the observed inhibitory activity of these congeners. From both approaches it is revealed that more hydrophobic susbtituents at 4-R 1 , a non-hydrogen bond acceptor substitutent, preferably a -F substituent, at 3-R 1 in 4-phenyl ring of 3(2H)furanone scaffold improve inhibitory action of a compound. The substituents exhibiting collective molecular bulk smaller than spirocyclopentyl at X and Y positions are preferred as these geminal positions seems to be involved in steric interation. Similarly, 4-aminosulfonyl in 5 aryl ring of 3(2H)furanone moiety emerged as a better choice than 4-methylsulfonyl substitution.
however, led to disruption of beneficial prostaglandinvaldecoxib 13 , and etoricoxib 14, 15 . As more clinical data regulated processes 2, 3 . The toxic effects causing accumulate, it may become possible to differentiate induction of gastrointestinal mucosal lesions, perforations, profiles of COX-2 inhibitors based on efficacy and safety. bleeding and decreased renal function 4 have, therefore, There have been some, but not conclusive, attempts to restricted their therapeutic usefulness. differentiate profiles of COX-2 inhibitors 16, 17 Earlier, it was believed that cyclooxygenase (COX) was a More recently, the structure-activity relationship (SAR) single enzyme present constitutively in various tissues and pharmacological properties of 4,5-diaryl-3(2H) including the gastrointestinal (GI) tract, the kidneys, and furanone derivatives as a novel class of highly potent the platelets and its inhibition would lead to both selective COX-2 inhibitors have been reported 18 . These beneficial and detrimental effects 5 . Recently, it was analogues having 3(2H) furanone moiety are structurally . , .
suggested that the COX enzyme existed in two forms, namely, the inducible form (COX-2) that is expressed during inflammatory conditions and the constitutive isoform (COX-1) that produces physiologically important prostaglandins (PGs) present in gastrointestinal tract and kidney [6] [7] [8] . It is realized that it is the inhibition of COX-1 that causes the various side effects seen with NSAIDs. Such findings coupled with the discovery of COX-2 suggested that selective inhibitors of COX-2 might constitute a novel approach to the treatment of *For correspondence E-mail: psingh_sikar@rediffmail.com similar to celecoxib and rofecoxib. Such a study was, however, aimed only at the alteration of substituents at different positions of 3(2H) furanone moiety on qualitative basis and provided no rationale to reduce the trial-and error factors. Hence, a quantitative SAR (QSAR) study on these analogues was performed, so, as to provide the rationale for drug-design and to explore the possible mechanism of their action on molecular level.
MATERIALS AND METHODS
The reported compounds 18 , depicted by Fig. 1 and listed in Table 1 , were subjected to Fujita-Ban and Hansch type of analyses. The biological inhibitory effects towards the human COX-2 enzyme and appropriate physicochemical parameters are also listed in Table 1 . The activity data, evaluated as IC 50 , represent the concentration of a compound to accomplish 50% inhibition of the human COX-2 enzyme. The same are given as logIC 50 on molar basis. The most suitable descriptors were found to be the hydrophobic constant, π, and the hydrogen-bond acceptor parameter, HA that were taken directly from the compilation of Hansch et al. 19 Besides these parameters, some binary variables were also used parent structure.
The Fujita-Ban approach 20 is based on an additivity principle, in which biological activity, BA is given as, BA = ∑a j X j + µ -(1), where X j is the jth substituent with a value of 1 if present and 0 if not at some specific position. The numerals a j and µ are respectively the contribution of the jth substituent (generally the hyrdrogen) to BA and theoretical biological activity of the (unsubstituted) reference compound of the series. The linear equations generated from Eqn. 1 were solved by the method of to account for the effects due to specific variations in the least squares for the values of unknown's a present communication both the Fujita-Ban and the Hansch type of approaches were used to derive the QSAR results. The required software for these analyses were developed in our laboratory and are being extensively used in the QSAR studies as a part of our research programme pertaining to drug-design.
RESULTS AND DISCUSSION
Initially all compounds of Table 1 were used in the construction of the Fujita-Ban matrix with compound 1 as the reference congener. As per the requirement of this approach, all these compounds have similar substitutional variations at a given position, at least in two or more congeners. Tabulation of this matrix of 42 linear equations in 18 unknowns including the contribution of parent compound is avoided here for the sake of brevity. These equations were solved for the unknowns a employing multiple regression analysis (MRA). The contributions of various substituents obtained thereby are summarized in the third column of Observed -logIC 50 observed activities. The±data mentioned within parentheses (Table 2 ) represent 90% confidence intervals of unknown variables. Obviously, these statistical parameters reflect the significance of derived results for a data set of 42 compounds. However, a close examination at the calculated activity values of these compounds has revealed that compound 36 is not following the trend similar to the other members of the series as its deviation from the observed activity value is comparatively much higher. This compound seems to have an error in the experimental determination of its activity and thus it was ignored in the follow up study. In doing so, the corresponding row was removed from the Fujita-Ban www.ijpsonline.com matrix and the MRA of resulting matrix leads to the results listed in the last column of Table 1 , are now in close agreement with the observed ones. The substituents, to be incorporated at different positions of the parent moiety, that make higher positive contributions to -logIC 50 may be used to design n= 41, r 2 = 0.828, s = 0.301, F (5,35)= 33.747, q 2 = 0.745 -(2) for further discussion. Here, the hydrophobic constants for the substituents of 3-and 4-(meta-and para-) positions in 4-phenyl ring of 3 (2H)furanone scaffold were added to give π 3+4 descriptor while the hydrogen bond acceptor, HA 3 parameter for 3-substituents in the same ring appeared to be an important descriptor. The binary variable, IXY, is accounting for collective molecular bulk of XY-substituents bigger than spirocyclopentyl moiety. Thus a value equal to 1 was arbitrarily taken for Et, Et and spirocyclohexyl moiety and more active compounds of the series in future.
0 for other substituents. It is to be noted that the spirocyclopentyl moiety occupies a smaller space than the It is important to mention that the non-parametric approach diethyl substitutions. Consideration of such a descriptor such as Fujita-Ban or Free-Wilson cannot extrapolate has steeply increased the significance of QSAR [Eqn. 3, beyond the substituents used in the training set whereas Table 3 ]. The second binary variable, IZ accounted for the parametric Hansch type of approach, followed next the presence of -NH 2 substituent at Z. Thus a value for the same training set can do so. For this purpose, a equal to 1 or 0 for IZ, in that order, identifies the number of physicochemical descriptors in conjunction with presence of 4-aminosulfonyl or 4-methylsulfonyl binary variables were employed to obtain the final substitution in 5-aryl ring of 3 (2H) 1, are in close agreement with the observed ones. The Once the appropriate parameters were found then their plot of observed versus calculated -logIC combinations for different positions were also attempted and the Fujita-Ban study is also given in fig. 2 to to reduce the number of independent descriptors to demonstrate the goodness of fit and to show systematic account for meaningful correlations. The descriptors variations of observed versus calculated activities in the accounting for significance of results in statistical sense present congeneric series. That the variables used in were then retained for exploration of further QSAR Eqn. 2 have no mutual correlation is shown in Table 4 Table 3 and
All derived QSAR equations were further subjected to a the last equation included therein is reproduced as Eqn.
validation test 21 by leave-one-out (LOO) procedure. This 2, -logIC 50 = 0.307 (±0.19) π 3+4 -0.437 (±0.39)HA 3 -1.390 method creates a number of modified data sets by taking (±0.28)IXY + 0.615 (±0.19)IZ + 0.334 (±0.20)IR 1 + 7.204, away one compound from the parent data set in such a way that each observation is taken away once and once only. Then one model is developed for each reduced scaffold is one of the important quantifying parameter governing the COX-2 inhibition activity. The substituents of these two positions having relatively higher π-values are leading improved value of inhibition activity. Additionally, a-F substitution in 3-position in this ring is also a valid option to improve COX-2 activity (positive regression coefficient of IR 1 in Eqn. 2). However, hydrogen bond acceptor substituent at 3-R 1 contributed negatively (negative coefficient of HA 3 in Eqn. 2) to activity and is, therefore, least preferred. Alternatively, it may be stated that a non-hydrogen bond acceptor data set and the activity value of the deleted observation substituent such as a -F at 3-R is predicted from the model. The squared difference substituent at 4-R 1 are the preferred substitutions of 4 between predicted and observed activity values are phenyl ring attached to 3(2H)furanone moiety. The roles added to give the predictive residual sum of squares of remaining structural variations in parent structure are (PRESS). The cross-validation index, q 2 was calculated also evident from the regression coefficient associated from the ratio of PRESS to the sum of squares of the with binary variable. The negative coefficient of IXY, observed values (SSY). To be a reasonable QSAR demands for the substituents exhibiting collective model, q 2 should be greater than 0.6, while a value ³ 0.9 molecular bulk smaller than spirocyclopentyl at X and Y represents an excellent model. Eqn. 2 was further positions. Similarly, the positive coefficient of IZ reflects subjected to bootstrap analysis by making use of the that 4-aminosulfonyl is a better substitution than 4 external validation method (EVM). In this approach, a methylsulfonyl in 5-aryl ring of 3(2H)furanone moiety. few compounds were considered in the test set and Such guidelines may, further be used to synthesize more were left out to derive a correlation equation on effective inhibitors of COX-2. Following above strategy remainders. The equation was then used to predict the with reference to QSAR Eqn. 2, a few new compounds activities of compounds in the test set. In this way, listed in Table 6 , may be designed which have activity several equations were obtained and are listed in Table 5 values higher than the calculated activity values of corresponding to left out compounds of test set. The compounds reported in the original data set. predicted activities for these compounds are given in Table 1 for the sake of comparison. These activities From both the approaches, a few conclusions are now were found in close agreement with the observed ones.
evinced. The more hydrophobic substituent at 4-positions, a non-hydrogen bond acceptor substituent such as a -F at From Eqn. 2, it appears that the hydrophobic nature of 3-3-position of 4-phenyl ring of 3(2H)furanone moiety and 4-R 1 substituents in 4-phenyl ring of 3(2H)furanone improve the inhibitory action of a compound. The Fujita- -statistics obtained for n (=41) data points and k (= 1,2,3,4,5) independent variable(s). 
